
zzso zzso virus zzso infection is a representative opportunistic infection in patients with zzso zzso with a high zzso of zzso Many studies on the risk factors of zzso infection in this patient group have been zzso However, few data have been reported exploring zzso infection during systemic chemotherapy in solid cancer zzso 

We zzso analyzed 92 patients diagnosed with zzso infection between April 2001 and July 2010 during systemic chemotherapy for solid zzso All patients had received zzso prophylaxis for zzso 

The median age at the time of diagnosis of zzso infection was zzso years zzso zzso and the majority of patients zzso did not have zzso Eighty-one patients zzso received chemotherapy for locally advanced or zzso disease and 11 zzso had zzso chemotherapy after zzso zzso Of 92 patients, 14 zzso had zzso cell lung cancer and 10 zzso breast zzso All patients had a median of 2 zzso zzso zzso zzso At the time of diagnosis, 55 patients zzso were receiving zzso chemotherapy and 15 zzso more than zzso zzso The mean white blood cell, zzso and zzso level was zzso zzso zzso zzso and zzso zzso zzso On analysis for disease evaluation at the time nearest to diagnosis of zzso infection, only 14 patients zzso revealed tumor response to zzso After the diagnosis of zzso infection, all patients were treated with zzso zzso None of the patients experienced failure of therapy for zzso 

We reported zzso infection during systemic chemotherapy in solid cancer zzso Patients may have a relatively poor tumor response to chemotherapy at the time nearest to diagnosis of zzso zzso A prospective or matched controlled trial is needed to confirm this zzso 

